Literature DB >> 11818157

Adult pneumococcal vaccination: a review of physician and patient barriers.

Tammy A Mieczkowski1, Stephen A Wilson.   

Abstract

Despite the Healthy People 2010 goal of a pneumococcal polysaccharide vaccine (PPV) vaccination rate of 90% by year 2010, rates remain low and racial disparities exist. This paper systematically reviewed medical literature published between 1981 and 2000 regarding physician and patient knowledge, attitudes, and practices related to pneumococcal vaccination. Among physicians the vaccine is generally believed to be efficacious and safe but difficulty in determining the vaccination status and lack of knowledge regarding re-vaccination were reported as barriers to vaccination. Among patients, there is a lack of awareness among patients of the existence of PPV. Furthermore, a large percentage of patients do not recall being informed about or recommended to receive the vaccine by their physician.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11818157     DOI: 10.1016/s0264-410x(01)00463-7

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  20 in total

1.  Cost-effectiveness of adult vaccinations: A systematic review.

Authors:  Andrew J Leidner; Neil Murthy; Harrell W Chesson; Matthew Biggerstaff; Charles Stoecker; Aaron M Harris; Anna Acosta; Kathleen Dooling; Carolyn B Bridges
Journal:  Vaccine       Date:  2018-12-04       Impact factor: 3.641

2.  Barriers to Pretransplant Immunization: A Qualitative Interview Study of Pediatric Solid Organ Transplant Stakeholders.

Authors:  Amy G Feldman; Rebekah Marsh; Allison Kempe; Megan A Morris
Journal:  J Pediatr       Date:  2020-07-15       Impact factor: 4.406

Review 3.  Interventions to improve influenza and pneumococcal vaccination rates among community-dwelling adults: a systematic review and meta-analysis.

Authors:  Darren Lau; Jia Hu; Sumit R Majumdar; Dale A Storie; Sandra E Rees; Jeffrey A Johnson
Journal:  Ann Fam Med       Date:  2012 Nov-Dec       Impact factor: 5.166

4.  Pneumococcal Vaccination in Adults.

Authors:  Tsering Y Sherpa; Howard L Leaf
Journal:  Curr Infect Dis Rep       Date:  2005-05       Impact factor: 3.725

5.  Understanding the reasons for the underuse of pneumococcal vaccination by community-dwelling older African Americans.

Authors:  Linda G Jones; Yan Zhang; Mustafa I Ahmed; O James Ekundayo; Shamima Akhter; Patricia Sawyer; Inmaculada Aban; Richard V Sims; Ali Ahmed
Journal:  J Am Geriatr Soc       Date:  2010-12       Impact factor: 5.562

6.  Focus group interviews on racial and ethnic attitudes regarding adult vaccinations.

Authors:  Nicholas A Daniels; Teresa Juarbe; Martha Rangel-Lugo; Gina Moreno-John; Eliseo J Pérez-Stable
Journal:  J Natl Med Assoc       Date:  2004-11       Impact factor: 1.798

7.  Factors associated with pneumococcal vaccination among an urban elderly population in China.

Authors:  Shijun Liu; Erping Xu; Yan Liu; Yuyang Xu; Jun Wang; Jian Du; Xiaoping Zhang; Xinren Che; Wenwen Gu
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

8.  Understanding adult vaccination in urban, lower-socioeconomic settings: influence of physician and prevention systems.

Authors:  Richard K Zimmerman; Mary Patricia Nowalk; Melissa Tabbarah; Jonathan A Hart; Dwight E Fox; Mahlon Raymund
Journal:  Ann Fam Med       Date:  2009 Nov-Dec       Impact factor: 5.166

9.  Physician attitudes and beliefs associated with patient pneumococcal polysaccharide vaccination status.

Authors:  Tammy A Santibanez; Richard Kent Zimmerman; Mary Patricia Nowalk; Ilene Katz Jewell; Inis J Bardella
Journal:  Ann Fam Med       Date:  2004 Jan-Feb       Impact factor: 5.166

10.  Quadrivalent Meningococcal Vaccine Uptake Among Men Who Have Sex With Men During a Meningococcal Outbreak in Los Angeles County, California, 2016-2017.

Authors:  Ian W Holloway; Elizabeth S C Wu; Jennifer Gildner; Vincent L Fenimore; Diane Tan; Laura Randall; Paula M Frew
Journal:  Public Health Rep       Date:  2018 Sep/Oct       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.